Home > Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 49 p.

[img]
Preview
PDF (Risk assessment - furanylfentanyl)
726kB

This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 15 November 2017, the Council decided that furanylfentanyl should be subject to control measures across the Member States. Furanylfentanyl is known from the scientific literature. Fentanyl is a fast but short-acting synthetic opioid that has been widely used in clinical practice.

Table of contents:
• EMCDDA actions on monitoring and responding to new drugs
• EMCDDA–Europol Joint Report on furanylfentanyl: a summary
• Risk Assessment Report of a new psychoactive substance: furanylfentanyl
• Annex 1: Technical report on furanylfentanyl
• Council Decision on subjecting furanylfentanyl to control measures
• Participants of the risk assessment meeting


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:New psychoactive substance
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:December 2017
Pages:49 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Related URLs:
Subjects:B Drugs and alcohol substances > Opioids (opiates)
B Drugs and alcohol substances > New (novel) psychoactive substances
J Health care, prevention and rehabilitation > Risk and needs assessment > Risk assessment
J Health care, prevention and rehabilitation > Drugs and alcohol prevention > Drugs and alcohol use harm reduction
VA Geographic area > Europe

Repository Staff Only: item control page